Article
Behavioral-transcriptomic landscape of engineered T cells targeting human cancer organoids
2021-05-05
Abstract excerpt
<h4>Summary</h4> Cellular immunotherapies are rapidly gaining clinical importance, yet predictive platforms for modeling their mode of action are lacking. Here, we developed a dynamic immuno-organoid 3D imaging-transcriptomics platform; BEHAV3D, to unravel the behavioral and underlying molecular mechanisms of solid tumor targeting. Applied to an emerging cancer metabolome-sensing immunotherapy: TEGs, we first dem...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 79db4bee-5094-56be-97cf-11e8f8484a0c
- DOI
- 10.1101/2021.05.05.442764
